Kodali et al.[74], demonstrated that 4E-BP1 expression was more commonly detectable in mature neoplasms (including FL, DLBCL and small lymphocytic lymphoma (SLL), the tissue-based counterpart of CLL) compared to non-malignant samples, whereas levels of 4E-BP1 phosphorylation were more variable between samples. Here, EIF4EBP1 is linked to neoplasm.